Targeted Therapies for Perihilar Cholangiocarcinoma.
biliary tract cancer
cholangiocarcinoma
extrahepatic
pCCA
perihilar
targeted therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
07
03
2022
revised:
29
03
2022
accepted:
30
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Perihilar cholangiocarcinoma (pCCA) is the anatomical sub-group of biliary tract cancer (BTC) arising between the second-order intrahepatic bile ducts and the cystic duct. Together with distal and intrahepatic cholangiocarcinoma (dCCA and iCCA; originating distal to, and proximal to this, respectively), gallbladder cancer (GBC) and ampulla of Vater carcinoma (AVC), these clinicopathologically and molecularly distinct entities comprise biliary tract cancer (BTC). Most pCCAs are unresectable at diagnosis, and for those with resectable disease, surgery is extensive, and recurrence is common. Therefore, the majority of patients with pCCA will require systemic treatment for advanced disease. The prognosis with cytotoxic chemotherapy remains poor, driving interest in therapies targeted to the molecular nature of a given patient's cancer. In recent years, the search for efficacious targeted therapies has been fuelled both by whole-genome and epigenomic studies, looking to uncover the molecular landscape of CCA, and by specifically testing for aberrations where established therapies exist in other indications. This review aims to provide a focus on the current molecular characterisation of pCCA, targeted therapies applicable to pCCA, and future directions in applying personalised medicine to this difficult-to-treat malignancy.
Identifiants
pubmed: 35406560
pii: cancers14071789
doi: 10.3390/cancers14071789
pmc: PMC8997784
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Oncogene. 2007 May 14;26(22):3291-310
pubmed: 17496923
Mol Biol Int. 2014;2014:852748
pubmed: 25276427
Lancet Oncol. 2014 Jul;15(8):819-28
pubmed: 24852116
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Int J Mol Sci. 2018 May 09;19(5):
pubmed: 29747443
Eur J Cancer. 2012 Jan;48(2):196-201
pubmed: 22176869
Future Oncol. 2021 Feb;17(6):637-648
pubmed: 33300372
Nat Genet. 2013 Dec;45(12):1474-8
pubmed: 24185513
Lung Cancer (Auckl). 2021 Oct 07;12:115-122
pubmed: 34675734
Lancet Oncol. 2020 Jun;21(6):796-807
pubmed: 32416072
J Gastroenterol Hepatol. 2014 May;29(5):1119-25
pubmed: 24372748
Nat Commun. 2015 Jan 30;6:6120
pubmed: 25636086
Lancet Oncol. 2010 Dec;11(12):1142-8
pubmed: 21071270
Br J Cancer. 2013 Aug 20;109(4):915-9
pubmed: 23900219
Br J Cancer. 2014 Feb 18;110(4):882-7
pubmed: 24423918
Clin Cancer Res. 2016 Feb 15;22(4):813-20
pubmed: 26880610
Eur J Cancer. 2018 Mar;92:11-19
pubmed: 29413685
Science. 2017 Mar 17;355(6330):1152-1158
pubmed: 28302823
Clin Cancer Res. 2014 Apr 1;20(7):1884-90
pubmed: 24478380
Expert Opin Ther Targets. 2012 Jan;16(1):103-19
pubmed: 22239440
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Lancet Oncol. 2021 Oct;22(10):1468-1482
pubmed: 34592180
J Cancer Res Clin Oncol. 2005 Oct;131(10):649-52
pubmed: 16032426
J Clin Oncol. 2018 Jan 20;36(3):276-282
pubmed: 29182496
Hepatology. 2018 Jul;68(1):113-126
pubmed: 29360137
BMC Cancer. 2016 Feb 24;16:153
pubmed: 26912134
Ann Oncol. 2014 Aug;25(8):1597-603
pubmed: 24827133
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
Br J Cancer. 2008 Jan 29;98(2):418-25
pubmed: 18087285
J Clin Oncol. 2011 Jun 10;29(17):2357-63
pubmed: 21519026
Cell Mol Life Sci. 2008 May;65(10):1566-84
pubmed: 18259690
Angiogenesis. 2017 Nov;20(4):409-426
pubmed: 28660302
Cancer Chemother Pharmacol. 2009 Sep;64(4):777-83
pubmed: 19169683
Surgery. 2013 Jun;153(6):811-8
pubmed: 23499016
Clin Cancer Res. 2019 Aug 15;25(16):4888-4897
pubmed: 31088831
Am J Gastroenterol. 2010 May;105(5):1123-32
pubmed: 19997097
Cancer Cell Int. 2020 Jan 13;20:16
pubmed: 31956294
Eur J Cancer. 2014 Dec;50(18):3125-35
pubmed: 25446376
J Hepatol. 2020 Aug;73(2):315-327
pubmed: 32173382
N Engl J Med. 2021 Jun 24;384(25):2371-2381
pubmed: 34096690
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
J Clin Oncol. 2010 Jul 20;28(21):3491-7
pubmed: 20530271
Hepatogastroenterology. 2011 Jan-Feb;58(105):20-5
pubmed: 21510280
Lancet Oncol. 2015 Aug;16(8):967-78
pubmed: 26179201
Lancet Oncol. 2019 May;20(5):663-673
pubmed: 30922733
World J Gastroenterol. 2018 Sep 28;24(36):4152-4163
pubmed: 30271080
Oncologist. 2023 Jul 5;28(7):e520-e525
pubmed: 36994874
Oncology. 2012;82(3):175-9
pubmed: 22433475
J Gastroenterol. 2008;43(12):959-66
pubmed: 19107340
PLoS One. 2011 Jan 06;6(1):e15640
pubmed: 21253578
J Blood Med. 2016 Sep 02;7:171-80
pubmed: 27621679
Lancet Oncol. 2021 Sep;22(9):1290-1300
pubmed: 34339623
Recent Results Cancer Res. 2018;211:45-56
pubmed: 30069758
Am J Clin Oncol. 2018 Jul;41(7):649-655
pubmed: 27849649
Cancer Metastasis Rev. 2017 Mar;36(1):141-157
pubmed: 27981460
Hum Pathol. 2013 Dec;44(12):2768-73
pubmed: 24139215
Genes Chromosomes Cancer. 2008 May;47(5):363-7
pubmed: 18181165
Br J Cancer. 2015 Jul 28;113(3):365-71
pubmed: 26151455
Invest New Drugs. 2012 Aug;30(4):1646-51
pubmed: 21748296
PLoS One. 2013 May 21;8(5):e64186
pubmed: 23704979
Br J Cancer. 2010 Aug 10;103(4):469-74
pubmed: 20628385
Cancer Discov. 2018 Feb;8(2):184-195
pubmed: 29247021
Gut Liver. 2018 May 15;12(3):236-245
pubmed: 28783896
Pharmacol Ther. 2017 Nov;179:171-187
pubmed: 28564583
Lancet Oncol. 2020 May;21(5):671-684
pubmed: 32203698
Cold Spring Harb Mol Case Stud. 2017 Sep 1;3(5):
pubmed: 28619747
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
J Clin Med. 2020 Jun 07;9(6):
pubmed: 32517311
J Surg Oncol. 2001 Feb;76(2):121-6
pubmed: 11223838
Gut. 2003 May;52(5):706-12
pubmed: 12692057
Ann Oncol. 2015 Mar;26(3):542-7
pubmed: 25538178
Br J Surg. 2017 Mar;104(4):426-433
pubmed: 28138968
Cancer Discov. 2017 Oct;7(10):1116-1135
pubmed: 28667006
JCO Precis Oncol. 2019 Oct 17;3:
pubmed: 32923849
J Community Support Oncol. 2014 Feb;12(2):48-9
pubmed: 24971404
Ann Oncol. 2020 Sep;31(9):1169-1177
pubmed: 32464280
Cancer Res Treat. 2020 Apr;52(2):594-603
pubmed: 32019287
J Gastrointest Oncol. 2019 Aug;10(4):751-765
pubmed: 31392056
Ann Surg. 1992 Jan;215(1):31-8
pubmed: 1309988
Br J Cancer. 2018 Apr;118(7):966-971
pubmed: 29527009
Drugs. 2020 Jun;80(9):923-929
pubmed: 32472305
BMC Cancer. 2020 Nov 16;20(1):1105
pubmed: 33198671
Semin Cancer Biol. 2019 Dec;59:125-132
pubmed: 31323288
Lancet Oncol. 2012 Feb;13(2):181-8
pubmed: 22192731
Clin Cancer Res. 2007 Aug 15;13(16):4795-9
pubmed: 17699857
Cancer Discov. 2015 Jan;5(1):25-34
pubmed: 25527197
Anticancer Res. 2020 Jul;40(7):4123-4129
pubmed: 32620661
Clin Cancer Res. 2019 Jul 1;25(13):3753-3758
pubmed: 30787022
Am J Pathol. 2003 Jul;163(1):217-29
pubmed: 12819026
J Hematol Oncol. 2015 May 29;8:58
pubmed: 26022204
Br J Cancer. 2019 Jan;120(2):165-171
pubmed: 30420614
Sci Transl Med. 2017 Feb 1;9(375):
pubmed: 28148839
Gastroenterology. 2013 Dec;145(6):1215-29
pubmed: 24140396
Oncologist. 2020 Oct;25(10):886-893
pubmed: 32353192
Cancer. 2016 Feb 15;122(4):574-81
pubmed: 26540314
Cancer. 2016 Dec 15;122(24):3838-3847
pubmed: 27622582
Oncol Res Treat. 2021;44(1-2):20-27
pubmed: 33279901
Cancer. 2021 Apr 15;127(8):1293-1300
pubmed: 33289918
J Hepatol. 2009 Jul;51(1):93-101
pubmed: 19446907
Am J Clin Pathol. 2020 Apr 15;153(5):598-604
pubmed: 31844887
Eur J Cancer. 2012 Jul;48(10):1466-75
pubmed: 22446022
J Hepatol. 2020 Jan;72(1):95-103
pubmed: 31536748
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Nat Rev Drug Discov. 2020 Aug;19(8):533-552
pubmed: 32528145
Lancet Oncol. 2021 May;22(5):690-701
pubmed: 33798493
Br J Cancer. 2019 Jan;120(1):109-114
pubmed: 30377340
Lancet Oncol. 2020 Sep;21(9):1234-1243
pubmed: 32818466
Lancet. 2021 Jan 30;397(10272):428-444
pubmed: 33516341
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
N Engl J Med. 2004 May 20;350(21):2129-39
pubmed: 15118073
Drugs. 2021 Jul;81(11):1355-1360
pubmed: 34279850
N Engl J Med. 2018 Jun 21;378(25):2386-2398
pubmed: 29860938
Clin Cancer Res. 2016 Jan 1;22(1):259-67
pubmed: 26373574
Clin Case Rep. 2021 Mar 04;9(4):2259-2263
pubmed: 33936676
J Am Coll Surg. 2015 Dec;221(6):1041-9
pubmed: 26454735
Clin Cancer Res. 2018 Sep 1;24(17):4154-4161
pubmed: 29848569
J Hepatol. 2022 May;76(5):1109-1121
pubmed: 35167909
Cancer. 2019 Mar 15;125(6):902-909
pubmed: 30561756
Clin Cancer Res. 2006 Mar 15;12(6):1680-5
pubmed: 16551849
Br J Cancer. 2010 Jan 5;102(1):68-72
pubmed: 19935794
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):803-815
pubmed: 34358484
Ann Oncol. 2007 Jun;18 Suppl 6:vi31-4
pubmed: 17591828
N Engl J Med. 2012 Nov;367(18):1694-703
pubmed: 23020132
Lancet Oncol. 2010 Jan;11(1):48-54
pubmed: 19932054
Profiles Drug Subst Excip Relat Methodol. 2019;44:239-266
pubmed: 31029219
Lancet Gastroenterol Hepatol. 2019 Sep;4(9):711-720
pubmed: 31300360
Hepatobiliary Surg Nutr. 2020 Aug;9(4):414-424
pubmed: 32832493
PLoS One. 2014 Dec 23;9(12):e115383
pubmed: 25536104
Intern Med. 2020 Sep 15;59(18):2261-2267
pubmed: 32536644
N Engl J Med. 2010 Apr 8;362(14):1273-81
pubmed: 20375404
Chin Clin Oncol. 2020 Feb;9(1):6
pubmed: 32075397
Gastrointest Cancer Res. 2014 Mar;7(2):42-8
pubmed: 24799970
Lancet Oncol. 2021 Nov;22(11):1560-1572
pubmed: 34656226
Oncotarget. 2014 May 15;5(9):2839-52
pubmed: 24867389